Pre-exposure vaccination: Hypersensitivity to the active substance(s) or to any of the excipients listed in Description, to polymyxin B, to streptomycin, to neomycin or to any antibiotic of the same group, to a previous administration or to any vaccine containing the same components.
Vaccination should be postponed in case of febrile or acute diseases.
The Intradermal route must not be used in the following instances: individuals receiving long term corticosteroid or other immunosuppressive therapy or chloroquine; immunocompromised individuals; individuals, particularly children, with severe wounds, especially to the head and neck or presenting late for consultation.
Post-exposure vaccination: Given the fatal outcome of the declared rabies infection, there are no contraindications to post-exposure vaccination.
The Intradermal route must not be used in the following instances: individuals receiving long term corticosteroid or other immunosuppressive therapy or chloroquine; immunocompromised individuals; individuals, particularly children, with severe wounds, especially to the head and neck or presenting late for consultation.